Cite
MLA Citation
Philip Tatman et al.. “DDRE-43. SCREENING OF FDA-APPROVED COMPOUNDS FOR THE TREATMENT OF CHORDOMA, WITH IN VIVO VALIDATION USING THREE DIFFERENT XENOGRAFT MODELS, IDENTIFIES BRIGATINIB AS A POTENTIAL TREATMENT.” Neuro-oncology, vol. 23, 2021, pp. vi83–vi84. http://access.bl.uk/ark:/81055/vdc_100146090306.0x000013